← FDA Drug Approvals (Drugs@FDA)

EPINEPHRINE

NDA · New Drug Application · Sponsor: BAXTER HLTHCARE CORP · Approved 2026-03-30

Drug application

FDA Application #

NDA220626

Application type

New Drug Application

Brand name

EPINEPHRINE

Generic name

EPINEPHRINE

Active ingredients

EPINEPHRINE

Dosage form

SOLUTION

Route

INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

Marketing status

Prescription

Sponsor

BAXTER HLTHCARE CORP

Manufacturer

Baxter Healthcare Corporation

First approval

2026-03-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown